Three scientists -- Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) -- were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar lower in Taipei trading
01/05/2026 10:16 AM - Business
TSMC shares soar to record NT$1,650 Monday morning
01/05/2026 10:00 AM - Society
Taiwan headline news
01/05/2026 09:47 AM - Business
Taiwan shares open higher
01/05/2026 09:10 AM - Cross-Strait